fda sued over tirzepatide Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the Compounders protest as FDA removes
Description
You may have heard of the brand names, Ozempic and Wegovy.

If you're feeling unusually tired, dizzy, or dealing with a persistent headache on your GLP-1 journey, the culprit is often simpler than you think

This medication has been identified as Dupixent 300 mg/2 mL prefilled pen and is used for Eosinophilic Esophagitis, Chronic Rhinosinusitis With Nasal Polyps, Eczema, Prurigo Nodularis, and Asthma.

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.

Can they do the same for everyone else?

He asserts that the obvious hack consumers would do is to spend less on food, but the math doesnt add up, he shows in the first bar chart
